Development of anti-angiogenic tyrosine kinases inhibitors: molecular structures and binding modes.

about

Micelle-enhanced direct spectrofluorimetric method for the determination of linifanib: Application to stability studies.Pharmacodynamic and Pharmacokinetic Markers For Anti-angiogenic Cancer Therapy: Implications for Dosing and Selection of Patients.

P2860

Q46742830-D9C9D92A-D5F0-4A08-8D05-AD1EDE1E2920 Q50091855-8CF502DD-F7C4-4D90-AE14-D3D5314B5C93

P2860

Development of anti-angiogenic tyrosine kinases inhibitors: molecular structures and binding modes.

Item

http://www.wikidata.org/entity/Q38701634

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Development of anti-angiogenic ...... structures and binding modes.

@en

type

Item

label

Development of anti-angiogenic ...... structures and binding modes.

@en

prefLabel

Development of anti-angiogenic ...... structures and binding modes.

@en

P1476

Development of anti-angiogenic ...... structures and binding modes.

@en

P2093

Jingya Zhang

http://www.w3.org/2001/XMLSchema#string

Linna Zhang

http://www.w3.org/2001/XMLSchema#string

Yuanyou Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Hallmarks of Cancer: The Next Generation

Cellular signaling by fibroblast growth factor receptors

Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases

Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitor

Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors

BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy

Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor

Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo[3,2-d]pyrimidine derivatives: novel VEGFR2 kinase inhibitors binding to inactive kinase conformation

Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors

P2888

s00280-016-2961-6

P304

905-926

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-016-2961-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Guisen Zhao

P577

2016-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1044729595

http://www.w3.org/2001/XMLSchema#string

P698

26781310

http://www.w3.org/2001/XMLSchema#string

Development of anti-angiogenic tyrosine kinases inhibitors: molecular structures and binding modes.

about

P2860

P2860

Development of anti-angiogenic tyrosine kinases inhibitors: molecular structures and binding modes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698